Skip to main content
Fig. 3 | Clinical Proteomics

Fig. 3

From: Label-free quantitative proteomics reveals aberrant expression levels of LRG, C9, FN, A1AT and AGP1 in the plasma of patients with colorectal cancer

Fig. 3

Scatter plots show relative expression levels of (A) LRG, (B) S100A8, (C) C9, (D) FN, (E) AGP1, and (F) A1AT from immunoblotting of individual plasma samples in the study-cohort and validation-cohort. All immunoblot results are provided in the supplementary data, Table S4 and S5. Green dots, Healthy control (HC); Red dots, Non-Metastatic CRC patients (NM); Blue dots, Metastatic CRC patients (M); Black dots, all CRC patients (CRC). Black lines represent the medians of samples in each group. Stars represent statistical significance calculated by non-parametric one-way ANOVA (Kruskal-Wallis) and Dunn’s multiple comparison test for the comparison among HC, NM and M groups; and non-parametric t-test (Mann-Whitney U test) for the comparison between HC and CRC groups. *, **, and *** represent p-value < 0.05, < 0.01, and < 0.001, respectively.

Back to article page

Clinical Proteomics

ISSN: 1559-0275